G673-0627 Screening compound: N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

G673-0627 Screening compound: N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide
G673-0627 Screening compound: N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G673-0627
N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G673-0627

Molecular Formula

C28H41N5O3 (C28 H41 N5 O3)

Compound Name

N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

IUPAC name

N-[3-(azepan-1-yl)propyl]-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxalin-5-yl]acetamide

SMILES

O=C(CN1c(cc(cc2)C(N3CCCC3)=O)c2N(CCCC2)C2C1=O)NCCCN1CCCCCC1

InChI

InChI=1S/C28H41N5O3/c34-26(29-13-9-16-30-14-4-1-2-5-15-30)21-33-25-20-22(27(35)31-17-7-8-18-31)11-12-23(25)32-19-6-3-10-24(32)28(33)36/h11-12,20,24H,1-10,13-19,21H2,(H,29,34)/t24-/m0/s1

InChI Key

FHUVYBBVIWCNLG-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD15028362

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.67

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.819

Distribution Coefficient, logD

-0.809

Water Solubility, LogSw

-2.48

Polar Surface Area

63.433

Acid Dissociation Constant (pKa)

15.09

Base Dissociation Constant (pKb)

10.03

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

67.90

G673-0627 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Immune system
  • animal
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G673-0627 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G673-0627?
Check Price and Availability of G673-0627, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G673-0627 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G673-0627
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G673-0627
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G673-0627 available by request